Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wiksten

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Memory & Cognition|January 29, 2011
Using semantic memory to find vs create a moodE F Loftus, S Wiksten, R P Abelson
Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2020
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III StudyAtul Deodhar, Ricardo Blanco, Eva Dokoupilová, et al.
Arthritis Research & Therapy|September 5, 2021
Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENTJürgen Braun, Ricardo Blanco, Helena Marzo-Ortega, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Memory & Cognition|January 29, 2011
Using semantic memory to find vs create a moodE F Loftus, S Wiksten, R P Abelson
Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2020
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III StudyAtul Deodhar, Ricardo Blanco, Eva Dokoupilová, et al.
Arthritis Research & Therapy|September 5, 2021
Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENTJürgen Braun, Ricardo Blanco, Helena Marzo-Ortega, et al.
Pageof 1